| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $258.0M | — | +70.6% |
| R&D Expense | $26.9M | — | +22.3% |
| SG&A Expense | $42.2M | — | +17.5% |
| Pre-tax Income | -$34.6M | — | +43.6% |
| Income Tax | $1.2M | — | +20.0% |
| Net Income | -$35.8M | — | +42.6% |
| EPS (Basic) | -$0.47 | — | +45.3% |
| EPS (Diluted) | -$0.47 | — | +45.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $374.3M | -2.8% | +21.1% |
| Short-term Investments | $19.5M | +38.3% | -4.9% |
| Total Assets | $1.96B | +1.7% | +5.5% |
| Total Liabilities | $1.44B | +3.4% | +9.8% |
| Stockholders' Equity | $518.0M | -2.9% | -5.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$600K | — | +98.7% |
| Capital Expenditures | $3.5M | — | +52.2% |
| Investing Cash Flow | -$34.6M | — | +14.1% |
| Financing Cash Flow | $26.2M | — | +31.0% |
| Free Cash Flow | -$4.1M | — | +91.7% |